Patents by Inventor Edvin Johannesen

Edvin Johannesen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080044350
    Abstract: The invention provides contrast agents for optical imaging of prostate cancer in patients. The contrast agents may be used in diagnosis of prostate cancer, for follow up of progress in disease development, for follow up of treatment of prostate cancer and for surgical guidance. Further, the invention provides methods for optical imaging of prostate cancer in patients.
    Type: Application
    Filed: December 17, 2004
    Publication date: February 21, 2008
    Inventors: Jo Klaveness, Edvin Johannesen, Helge Tolleshaug
  • Publication number: 20080019907
    Abstract: The invention provides contrast agents for optical imaging of vulnerable atherosclerotic plaque in patients. The contrast agents may be used in diagnosis of vulnerable atherosclerotic plaque, for follow up of progress in disease development, for follow up of treatment of vulnerable atherosclerotic plaque and for surgical guidance. Further, the invention provides methods for optical imaging of vulnerable atherosclerotic plaque in patients.
    Type: Application
    Filed: December 17, 2004
    Publication date: January 24, 2008
    Inventors: Jo Klaveness, Edvin Johannesen, Helge Tolleshaug
  • Publication number: 20070258904
    Abstract: The invention provides contrast agents for optical imaging of oesophageal cancer and Barrett's oesophagus in patients. The contrast agents may be used in diagnosis of oesophageal cancer and Barrett's oesophagus, for follow up of progress in disease development, for follow up of treatment of oesophageal cancer and Barrett's oesophagus and for surgical guidance. Further, the invention provides methods for optical imaging of oesophageal cancer and Barrett's oesophagus in patients.
    Type: Application
    Filed: December 17, 2004
    Publication date: November 8, 2007
    Inventors: Jo Klaveness, Edvin Johannesen, Helge Tolleshaug
  • Publication number: 20070212305
    Abstract: The invention provides contrast agents for optical imaging of lung cancer in patients. The contrast agents may be used in diagnosis of lung cancer, for follow up of progress in disease development, for follow up of treatment of lung cancer and for surgical guidance. Further, the invention provides methods for optical imaging of lung cancer in patients.
    Type: Application
    Filed: December 17, 2004
    Publication date: September 13, 2007
    Applicant: AMERSHAM HEALTH AS
    Inventors: Jo Klaveness, Edvin Johannesen, Helge Tolleshaug
  • Publication number: 20070116646
    Abstract: The invention provides contrast agents for optical imaging of endometriosis in patients. The contrast agent may be used in diagnosis of endometriosis, for follow-up of progress in disease development, and for follow-up of treatment of endometriosis. Further, the invention provides methods for optical imaging of endometriosis. The contrast agent has affinity for an abnormally expressed target associated with endometriosis. By abnormally expressed, is meant that the target is either overexpressed or downregulated. Endometriotic tissue containing a downregulated target may be identified by a low amount of bound contrast agent compared to normal tissue. In this situation, the amount of contrast agent should be less than 50% of that in normal tissue, preferably less than 10%.
    Type: Application
    Filed: September 28, 2004
    Publication date: May 24, 2007
    Inventors: Jo Klaveness, Edvin Johannesen, Helge Tolleshaug
  • Patent number: 7014839
    Abstract: The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: March 21, 2006
    Assignee: Amersham Health AS
    Inventors: Jo Klaveness, Bjorn Fuglaas, Pål Rongved, Edvin Johannesen, Paul Mark Henrichs, Wolfgang Hans Heinrich Gunther, Edward Richard Bacon, John Luke Toner, Gregory Lynn McIntire, Vinay C. Desai
  • Publication number: 20030157021
    Abstract: The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
    Type: Application
    Filed: November 1, 2002
    Publication date: August 21, 2003
    Inventors: Jo Klaveness, Bjorn Fuglaas, Pal Rongved, Edvin Johannesen, Paul Mark Henrichs, Wolfgang Hans Heinrich Gunther, Edward Richard Bacon, John Luke Toner, Gregory Lynn McIntire, Vinay C. Desai
  • Patent number: 6540981
    Abstract: The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: April 1, 2003
    Assignee: Amersham Health AS
    Inventors: Jo Klaveness, Bjorn Fuglass, Pål Rongved, Edvin Johannesen, Paul Mark Hendrichs, Wolfgang Hans Heinrich Gunther, Edward Richard Bacon, John Luke Toner, Gregory Lynn McIntire, Vinay C. Desai
  • Publication number: 20010022963
    Abstract: The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
    Type: Application
    Filed: December 11, 2000
    Publication date: September 20, 2001
    Applicant: Nycomed Imaging AS, a Oslo, Norway Corporation
    Inventors: Jo Klaveness, Bjorn Fuglass, Pal Rongved, Edvin Johannesen, Paul Mark Henrichs, Wolfgang Hans Heinrich Gunther, Edward Richard Bacon, John Luke Toner, Gregory Lynn McIntire, Vinay C. Desai
  • Patent number: 6159445
    Abstract: The present invention relates to the use of particulate materials as contrast agents in vivo light imaging.
    Type: Grant
    Filed: December 4, 1997
    Date of Patent: December 12, 2000
    Assignee: Nycomed Imaging AS
    Inventors: Jo Klaveness, Bjorn Fuglass, P.ang.al Rongved, Edvin Johannesen, Paul Mark Henrichs, Wolfgang Hans Heinrich, Edward Richard Bacon, John Luke Toner, Gregory Lynn McIntire, Vinay C. Desai